Cigna Group $CI Shares Sold by Empowered Funds LLC

Empowered Funds LLC lessened its holdings in Cigna Group (NYSE:CI) by 24.1% in the 1st quarter, Holdings Channel.com reports. The firm owned 99,271 shares of the health services provider’s stock after selling 31,587 shares during the quarter. Empowered Funds LLC’s holdings in Cigna Group were worth $26,481,000 at the end of the most recent reporting period.

A number of other hedge funds also recently bought and sold shares of the business. Wilkerson Advisory Group LLC purchased a new stake in shares of Cigna Group in the fourth quarter valued at approximately $25,000. Kemnay Advisory Services Inc. purchased a new position in shares of Cigna Group during the 4th quarter valued at approximately $29,000. Prosperity Bancshares Inc purchased a new position in shares of Cigna Group during the 4th quarter valued at approximately $29,000. Cedar Mountain Advisors LLC grew its stake in Cigna Group by 161.9% in the 1st quarter. Cedar Mountain Advisors LLC now owns 110 shares of the health services provider’s stock valued at $29,000 after acquiring an additional 68 shares during the period. Finally, Lodestone Wealth Management LLC acquired a new stake in Cigna Group in the 4th quarter valued at $32,000. Hedge funds and other institutional investors own 86.99% of the company’s stock.

Cigna Group Stock Up 0.6%

CI stock opened at $291.35 on Tuesday. The company has a market cap of $77.07 billion, a price-to-earnings ratio of 12.35, a PEG ratio of 1.12 and a beta of 0.29. The company has a current ratio of 0.73, a quick ratio of 0.73 and a debt-to-equity ratio of 0.69. Cigna Group has a 12 month low of $239.51 and a 12 month high of $315.47. The firm has a 50-day moving average of $286.15 and a two-hundred day moving average of $280.80.

Cigna Group (NYSE:CI) last issued its earnings results on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, topping the consensus estimate of $7.60 by $0.19. The business had revenue of $68.52 billion for the quarter, compared to analysts’ expectations of $66.29 billion. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.74 EPS. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, analysts forecast that Cigna Group will post 30.39 earnings per share for the current fiscal year.

Cigna Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 23rd. Shareholders of record on Tuesday, September 8th will be paid a dividend of $1.56 per share. The ex-dividend date of this dividend is Tuesday, September 8th. This represents a $6.24 dividend on an annualized basis and a yield of 2.1%. Cigna Group’s payout ratio is 26.45%.

Analyst Upgrades and Downgrades

A number of research firms have weighed in on CI. Barclays cut shares of Cigna Group from an “overweight” rating to an “equal weight” rating and reduced their price objective for the stock from $310.00 to $304.00 in a research report on Tuesday, May 26th. The Goldman Sachs Group boosted their target price on shares of Cigna Group from $335.00 to $340.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Wolfe Research reaffirmed an “outperform” rating and issued a $315.00 price target on shares of Cigna Group in a research note on Tuesday, June 16th. Wells Fargo & Company lifted their price objective on Cigna Group from $300.00 to $305.00 and gave the stock an “equal weight” rating in a report on Friday, May 1st. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Cigna Group in a report on Monday, June 1st. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have assigned a Buy rating and six have given a Hold rating to the stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $338.80.

Insider Buying and Selling at Cigna Group

In other news, CAO Jamie G. Kates sold 899 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $298.61, for a total transaction of $268,450.39. Following the transaction, the chief accounting officer owned 2,368 shares of the company’s stock, valued at approximately $707,108.48. The trade was a 27.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO David Cordani sold 201,878 shares of the company’s stock in a transaction dated Tuesday, May 12th. The shares were sold at an average price of $292.82, for a total transaction of $59,113,915.96. Following the completion of the sale, the chief executive officer directly owned 34,337 shares of the company’s stock, valued at $10,054,560.34. This represents a 85.46% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.60% of the stock is owned by corporate insiders.

Cigna Group Company Profile

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.